India's Torrent Pharmaceuticals falls after Q2 profit miss
** Shares of Torrent Pharmaceuticals TORP.NS fall 2.4% to
3,350 rupees
** The pharmaceuticals company's Q2 consol net profit and
revenue missed analysts' estimates, per data compiled by LSEG
** Smaller-than-expected profit due to shutdown of an
insulin manufacturing facility
** Q2 consol net profit up 17.4% Y/Y, rev rises 8.6% Y/Y
** Trading vols at 384,205, 1.3X the 30-day average
** TORP up ~45% YTD
(Reporting by Vijay Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Torrent Pharmaceuticals
See all newsHSBC sees steady growth for India healthcare; raise TP on Dr. Reddy's
India's Torrent Pharma's profit slips as R&D costs outweigh domestic demand
Brief: Torrent Pharma Q2 Consol Net Profit 5.34 Billion Rupees
GLP-1 boom in China, India, Brazil could create $22 bln market by 2035, J.P. Morgan says
India's Torrent Pharma Q2 earnings to get an acquisition lift, Nomura says